| MUC1 and HIF-1alpha signaling crosstalk induces anabolic glucose metabolism to impart gemcitabine resistance to pancreatic cancer SK Shukla, V Purohit, K Mehla, V Gunda, NV Chaika, E Vernucci, RJ King, ... Cancer cell 32 (1), 71-87. e7, 2017 | 472 | 2017 |
| Oncogenic KRAS Recruits an Expansive Transcriptional Network through Mutant p53 to Drive Pancreatic Cancer Metastasis MP Kim, X Li, J Deng, Y Zhang, B Dai, KL Allton, TG Hughes, C Siangco, ... Cancer discovery 11 (8), 2094-2111, 2021 | 89 | 2021 |
| Antineoplastic effects of auranofin in human pancreatic adenocarcinoma preclinical models MVR Perez, D Roife, B Dai, M Pratt, R Dobrowolski, Y Kang, X Li, ... Surgery Open Science 1 (2), 56-63, 2019 | 20 | 2019 |
| Compound NSC84167 selectively targets NRF2-activated pancreatic cancer by inhibiting asparagine synthesis pathway B Dai, JJ Augustine, Y Kang, D Roife, X Li, J Deng, L Tan, LA Rusling, ... Cell Death & Disease 12 (7), 693, 2021 | 7 | 2021 |
| Mutant p53 and oncogenic KRAS converge on CREB1 to drive pancreatic cancer metastasis MP Kim, X Li, J Deng, Y Zhang, B Dai, K Allton, T Hughes, C Siangco, ... Cancer Research 81 (13_Supplement), 2417-2417, 2021 | | 2021 |
| BP1003, a novel liposome-incorporated STAT3 antisense oligodeoxynucleotide inhibitor B Dai, AT Ashizawa, JJ Augustine, M Kim, J Fleming Cancer Research 79 (13_Supplement), 4786-4786, 2019 | | 2019 |
| CDK4/6 inhibition with lerociclib (G1T38) enhances response to PI3K or ERK inhibitors in high-throughput, ex vivo pancreatic PDX screens B Dai, DM Freed, JA Sorrentino, JJ Augustine, TG Hughes, Y Kang, ... Cancer Research 79 (13_Supplement), 4732-4732, 2019 | | 2019 |
